These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Role of the VEGF in virus-associated cancers. Tavakolian S; Tabaeian SP; Namazi A; Faghihloo E; Akbari A Rev Med Virol; 2024 Jan; 34(1):e2493. PubMed ID: 38078693 [TBL] [Abstract][Full Text] [Related]
3. The Role of Viruses in Carcinogenesis and Molecular Targeting: From Infection to Being a Component of the Tumor Microenvironment. Dzobo K OMICS; 2021 Jun; 25(6):358-371. PubMed ID: 34037476 [TBL] [Abstract][Full Text] [Related]
4. Specific in vivo knockdown of protein function by intrabodies. Marschall AL; Dübel S; Böldicke T MAbs; 2015; 7(6):1010-35. PubMed ID: 26252565 [TBL] [Abstract][Full Text] [Related]
5. Antibodies inside of a cell can change its outside: Can intrabodies provide a new therapeutic paradigm? Marschall AL; Dübel S Comput Struct Biotechnol J; 2016; 14():304-8. PubMed ID: 27570612 [TBL] [Abstract][Full Text] [Related]
6. Multifaceted roles for STAT3 in gammaherpesvirus latency revealed through Hogan CH; Owens SM; Reynoso GV; Liao Y; Meyer TJ; Zelazowska MA; Liu B; Li X; Grosskopf AK; Khairallah C; Kirillov V; Reich NC; Sheridan BS; McBride KM; Gewurz BE; Hickman HD; Forrest JC; Krug LT mBio; 2024 Feb; 15(2):e0299823. PubMed ID: 38170993 [TBL] [Abstract][Full Text] [Related]
7. Intracellular antibodies (intrabodies) for gene therapy of infectious diseases. Rondon IJ; Marasco WA Annu Rev Microbiol; 1997; 51():257-83. PubMed ID: 9343351 [TBL] [Abstract][Full Text] [Related]
8. Blocking translocation of cell surface molecules from the ER to the cell surface by intracellular antibodies targeted to the ER. Böldicke T J Cell Mol Med; 2007; 11(1):54-70. PubMed ID: 17367501 [TBL] [Abstract][Full Text] [Related]
9. Deciphering the Relationship between SARS-CoV-2 and Cancer. Costanzo M; De Giglio MAR; Roviello GN Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175509 [TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus-encoded EBNA1 and ZEBRA: targets for therapeutic strategies against EBV-carrying cancers. Daskalogianni C; Pyndiah S; Apcher S; Mazars A; Manoury B; Ammari N; Nylander K; Voisset C; Blondel M; Fåhraeus R J Pathol; 2015 Jan; 235(2):334-41. PubMed ID: 25186125 [TBL] [Abstract][Full Text] [Related]
11. A cell-penetrating whole molecule antibody targeting intracellular HBx suppresses hepatitis B virus via TRIM21-dependent pathway. Zhang JF; Xiong HL; Cao JL; Wang SJ; Guo XR; Lin BY; Zhang Y; Zhao JH; Wang YB; Zhang TY; Yuan Q; Zhang J; Xia NS Theranostics; 2018; 8(2):549-562. PubMed ID: 29290826 [No Abstract] [Full Text] [Related]
12. The E2F4/p130 Repressor Complex Cooperates with Oncogenic ΔNp73α To Inhibit Gene Expression in Human Papillomavirus 38 E6/E7-Transformed Keratinocytes and in Cancer Cells. Taverniti V; Krynska H; Venuti A; Straub ML; Sirand C; Lohmann E; Romero-Medina MC; Moro S; Robitaille A; Negroni L; Martinez-Zapien D; Masson M; Tommasino M; Zanier K mSphere; 2023 Apr; 8(2):e0005623. PubMed ID: 36883841 [TBL] [Abstract][Full Text] [Related]
13. Hepatitis B Gene Therapy Coming to Age. Soriano V AIDS Rev; 2018; 20(2):125-127. PubMed ID: 29938706 [TBL] [Abstract][Full Text] [Related]
14. Novel Molecular Targets and Mechanisms for Neuroprotective Modulation in Neurodegenerative Disorders. Azari A; Goodarzi A; Jafarkhani B; Eghbali M; Karimi Z; Hosseini Balef SS; Irannejad H Cent Nerv Syst Agents Med Chem; 2022; 22(2):88-107. PubMed ID: 35713146 [TBL] [Abstract][Full Text] [Related]
15. Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives. Schapira AH; Olanow CW; Greenamyre JT; Bezard E Lancet; 2014 Aug; 384(9942):545-55. PubMed ID: 24954676 [TBL] [Abstract][Full Text] [Related]
16. Galectin-9 Facilitates Epstein-Barr Virus Latent Infection and Lymphomagenesis in Human B Cells. Xu JX; Zhang R; Huang DJ; Tang Y; Ping LQ; Huang BJ; Huang HQ; Busson P; Li J Microbiol Spectr; 2023 Feb; 11(1):e0493222. PubMed ID: 36622166 [TBL] [Abstract][Full Text] [Related]
17. Conformational targeting of fibrillar polyglutamine proteins in live cells escalates aggregation and cytotoxicity. Kvam E; Nannenga BL; Wang MS; Jia Z; Sierks MR; Messer A PLoS One; 2009 May; 4(5):e5727. PubMed ID: 19492089 [TBL] [Abstract][Full Text] [Related]
19. Direct phage to intrabody screening (DPIS): demonstration by isolation of cytosolic intrabodies against the TES1 site of Epstein Barr virus latent membrane protein 1 (LMP1) that block NF-kappaB transactivation. Gennari F; Mehta S; Wang Y; St Clair Tallarico A; Palu G; Marasco WA J Mol Biol; 2004 Jan; 335(1):193-207. PubMed ID: 14659750 [TBL] [Abstract][Full Text] [Related]